Morbid obesity leads to increased skin autofluorescence independent of metabolic syndrome components

Creative Commons License

APAYDIN T., YAVUZ D.

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.52, sa.4, ss.1085-1092, 2022 (SCI-Expanded, Scopus, TRDizin)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 52 Sayı: 4
  • Basım Tarihi: 2022
  • Doi Numarası: 10.55730/1300-0144.5411
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.1085-1092
  • Anahtar Kelimeler: Advanced glycation end products, metabolic syndrome, morbid obesity, skin autofluorescence, GLYCATION END-PRODUCTS, BARIATRIC SURGERY, ENDOTHELIAL DYSFUNCTION, NONINVASIVE MARKER, ENDPRODUCTS, MORTALITY, RISK
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Marmara Üniversitesi Adresli: Evet

Özet

Background/aim: Obesity, diabetes mellitus, and metabolic syndrome (MetS) are associated with increased accumulated skin advanced glycation end products. We aimed to evaluate the association of MetS components with skin autofluorescence (SAF) in patients with morbid obesity.